Breathomix has developed BreathBase®, which includes eNose technology linked to a cloud-solution that aims to transform the way patients are diagnosed and managed by enabling rapid diagnostic answers in the doctor’s office.
BreathBase® is a combination of an easy-to-use eNose, SpiroNose®, and a constantly growing online reference database coupled with an AI-powered platform, which allow real-time, on-site analysis of composite exhaled biomarkers within seconds.
Breathomix is committed to target unmet medical needs across a wide range of disease areas including but not limited to chronic respiratory disease, cancer & infectious diseases by developing & bringing together all the necessary elements of data-driven medicine in the era of precision medicine.
Company’s Keywords:
breathomics, breath analysis, biomarkers, precision medicine, research, machine learning, data driven medicine
24
medical devices
Outlook, Microsoft Office 365, WordPress.org, Facebook Widget, Google Font API, Google Analytics, Facebook Login (Connect), Mobile Friendly, Nginx, reCAPTCHA, Google Tag Manager, ShareThis
2018